Cargando…

Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial

BACKGROUND: Acute otitis media (AOM) is among the most common paediatric conditions managed in primary care. Most recent estimates of the cost of AOM date from a decade ago and lack a full societal perspective. We therefore explored the societal cost of childhood AOM in the Netherlands within the se...

Descripción completa

Detalles Bibliográficos
Autores principales: van Uum, Rick T., Venekamp, Roderick P., Pasmans, Clémence T. B., de Wit, G. Ardine, Sjoukes, Alies, van der Pol, Alma C., Damoiseaux, Roger A. M. J., Schilder, Anne G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931516/
https://www.ncbi.nlm.nih.gov/pubmed/33663491
http://dx.doi.org/10.1186/s12913-021-06157-1
_version_ 1783660310685548544
author van Uum, Rick T.
Venekamp, Roderick P.
Pasmans, Clémence T. B.
de Wit, G. Ardine
Sjoukes, Alies
van der Pol, Alma C.
Damoiseaux, Roger A. M. J.
Schilder, Anne G. M.
author_facet van Uum, Rick T.
Venekamp, Roderick P.
Pasmans, Clémence T. B.
de Wit, G. Ardine
Sjoukes, Alies
van der Pol, Alma C.
Damoiseaux, Roger A. M. J.
Schilder, Anne G. M.
author_sort van Uum, Rick T.
collection PubMed
description BACKGROUND: Acute otitis media (AOM) is among the most common paediatric conditions managed in primary care. Most recent estimates of the cost of AOM date from a decade ago and lack a full societal perspective. We therefore explored the societal cost of childhood AOM in the Netherlands within the setting of a trial comparing the effectiveness of an intervention aimed at educating general practitioners (GPs) about pain management in AOM compared to usual care. METHODS: Economic analysis alongside a cluster randomised controlled trial conducted between February 2015 and May 2018 in 37 practices (94 GPs). In total, 224 children with AOM were included of which 223 (99%) completed the trial (intervention: n = 94; control: n = 129). The cost of AOM due to health care costs, patient and family costs, and productivity losses by parent caregivers were retrieved from study diaries and primary care electronic health records, during 28-day follow-up. We calculated mean cost (€ and $) per AOM episode per patient with standard deviations (SD, in €) regardless of study group assignment because there was no clinical effect of the trial intervention. In sensitivity analysis, we calculated cost in the intervention and usual care group, after exclusion of extreme outliers. RESULTS: Mean total AOM cost per patient were €565.93 or $638.78 (SD €1071.01); nearly 90% of these costs were due to productivity losses experienced by parents. After exclusion of outliers, AOM cost was €526.70 or $594.50 (SD €987.96) and similar in the intervention and usual care groups: €516.10 or $582.53 (SD €949.69) and €534.55 or $603.36 (SD €920.55) respectively. CONCLUSIONS: At €566 or $639 per episode, societal cost of AOM is higher than previously known and mainly driven by productivity losses by children’s parents. Considering its high incidence, AOM poses a significant economic burden that extends beyond direct medical costs. TRIAL REGISTRATION: Netherlands Trial Register no. NTR4920: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4920. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06157-1.
format Online
Article
Text
id pubmed-7931516
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79315162021-03-05 Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial van Uum, Rick T. Venekamp, Roderick P. Pasmans, Clémence T. B. de Wit, G. Ardine Sjoukes, Alies van der Pol, Alma C. Damoiseaux, Roger A. M. J. Schilder, Anne G. M. BMC Health Serv Res Research Article BACKGROUND: Acute otitis media (AOM) is among the most common paediatric conditions managed in primary care. Most recent estimates of the cost of AOM date from a decade ago and lack a full societal perspective. We therefore explored the societal cost of childhood AOM in the Netherlands within the setting of a trial comparing the effectiveness of an intervention aimed at educating general practitioners (GPs) about pain management in AOM compared to usual care. METHODS: Economic analysis alongside a cluster randomised controlled trial conducted between February 2015 and May 2018 in 37 practices (94 GPs). In total, 224 children with AOM were included of which 223 (99%) completed the trial (intervention: n = 94; control: n = 129). The cost of AOM due to health care costs, patient and family costs, and productivity losses by parent caregivers were retrieved from study diaries and primary care electronic health records, during 28-day follow-up. We calculated mean cost (€ and $) per AOM episode per patient with standard deviations (SD, in €) regardless of study group assignment because there was no clinical effect of the trial intervention. In sensitivity analysis, we calculated cost in the intervention and usual care group, after exclusion of extreme outliers. RESULTS: Mean total AOM cost per patient were €565.93 or $638.78 (SD €1071.01); nearly 90% of these costs were due to productivity losses experienced by parents. After exclusion of outliers, AOM cost was €526.70 or $594.50 (SD €987.96) and similar in the intervention and usual care groups: €516.10 or $582.53 (SD €949.69) and €534.55 or $603.36 (SD €920.55) respectively. CONCLUSIONS: At €566 or $639 per episode, societal cost of AOM is higher than previously known and mainly driven by productivity losses by children’s parents. Considering its high incidence, AOM poses a significant economic burden that extends beyond direct medical costs. TRIAL REGISTRATION: Netherlands Trial Register no. NTR4920: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4920. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06157-1. BioMed Central 2021-03-04 /pmc/articles/PMC7931516/ /pubmed/33663491 http://dx.doi.org/10.1186/s12913-021-06157-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
van Uum, Rick T.
Venekamp, Roderick P.
Pasmans, Clémence T. B.
de Wit, G. Ardine
Sjoukes, Alies
van der Pol, Alma C.
Damoiseaux, Roger A. M. J.
Schilder, Anne G. M.
Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
title Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
title_full Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
title_fullStr Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
title_full_unstemmed Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
title_short Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
title_sort cost of childhood acute otitis media in primary care in the netherlands: economic analysis alongside a cluster randomised controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931516/
https://www.ncbi.nlm.nih.gov/pubmed/33663491
http://dx.doi.org/10.1186/s12913-021-06157-1
work_keys_str_mv AT vanuumrickt costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT venekamproderickp costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT pasmansclemencetb costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT dewitgardine costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT sjoukesalies costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT vanderpolalmac costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT damoiseauxrogeramj costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial
AT schilderannegm costofchildhoodacuteotitismediainprimarycareinthenetherlandseconomicanalysisalongsideaclusterrandomisedcontrolledtrial